Device Trial Bill Lets Sponsors Forgo Extra CMS Review
This article was originally published in The Gray Sheet
Under legislation introduced in the House, device trials approved by FDA can be covered by Medicare without the need for CMS review.
You may also be interested in...
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?